Fitness equipment companies and apparel manufacturers alike are more focused than ever on creating precision fitness ...
Everest Group's narrative is shifting as the stock's price target rises, even while the underlying fair value estimate holds near $369 per share and key model assumptions stay largely intact. A modest ...
CorMedix surges on strong DefenCath uptake as sales climb while the Melinta acquisition expands and diversifies its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback